Journey Medical Corporation (DERM) vs Oramed Pharmaceuticals Inc. (ORMP)

A side-by-side comparison of Journey Medical Corporation and Oramed Pharmaceuticals Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — DERM vs ORMP

growth of $100 · dividends reinvested · last 5y
DERM -29.6% (-6.8%/yr)ORMP -82.6% (-29.5%/yr)DERM compounded faster over this window
020406080100Start $10020222023202420252026$70$17
DERM ORMP

DERM vs ORMP: by the numbers

  • •ORMP is the larger company ($182M vs $178M market cap).
  • •ORMP is profitable (3202.50% net margin) while DERM runs a net loss (-8.95%).
  • •ORMP pays a dividend (5.59% yield), while DERM has no payments in the available dividend history.

Metrics side by side

Valuation

MetricDERMORMP
P/E ratioN/A1.08
Forward P/EN/A1.00
P/S ratio2.61N/A
P/B ratio5.530.57
EV / EBITDA140.70N/A

Profitability

MetricDERMORMP
Gross margin62.24%0.65%
Operating margin-13.21%-754.40%
Net margin-8.95%3202.50%
ROE-19.01%55.08%
ROIC-5.22%-3.21%

Dividends

MetricDERMORMP
Dividend yieldN/A5.59%
Payout ratioN/A6.08%

Growth (annualized)

MetricDERMORMP
Revenue CAGR (5Y)6.75%N/A
Total return CAGR (5Y)N/A-25.80%

Frequently asked

Does DERM or ORMP pay a bigger dividend?
ORMP pays a dividend (5.59% yield), while DERM has no payments in the available dividend history.
Is DERM or ORMP more profitable?
ORMP runs the higher net margin — DERM at -8.95% versus ORMP at 3202.50%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.